FDA Issues Guidance for Industry Assessing Reproductive Toxicity FDA Issues Guidance for Industry Assessing Reproductive Toxicity

The FDA has issued new guidance for industry on assessing reproductive toxicity for anticancer pharmaceuticals and makes recommendations for pharmaceutical labeling.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news